.beta.-adrenergic receptor polymorphisms
CA 2305675 C · Owner: Liggett, Stephen Bryant · Inventors: Liggett, Stephen Bryant
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns polymorphisms in the .beta.1- and the .beta.2adrenergic receptors. The invention also pertains to methods and molecules for detecting such polymorphisms. The invention further pertains to the use of such molecules and methods in the diagnosis prognosis, and treatment , selection for cardiovascular diseases obesity, and diabetes.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 9, 1998 and granted December 9, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 9, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 9, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.